Bulgaria

BMI is maintaining its forecast of strong growth for the Bulgarian pharmaceutical market despite the release of conflicting data from the Bulgarian Drug Agency (BDA) and IMS

Bulgarian drug producer Sopharma sold more than half of its shares in late April 2006. On April 17, the company sold 48.77% of its share capital to the Bulgarian firms Telso, Telekomplect... 2006-04-26